MOH - NYSE
Molina Healthcare, Inc.
$184.82
+1.2%Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
At a Glance
Live Snapshotmoh
Revenue
Last Annual Value
45.43B
3-Year CAGR
12%
5-Year CAGR
19%
10-Year CAGR
12%
Molina Healthcare, Inc. Competitors Analysis of Revenue
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Molina Healthcare, Inc. NYSE:MOH | 45.43B | 10.1% | 10.3% | 9.9% | |
 AptarGroup, Inc. NYSE:ATR | 3.78B | 2.7% | 3.2% | 4.9% | |
 Henry Schein, Inc. NASDAQ:HSIC | 13.18B | 2.2% | 1.2% | 1.3% | |
 Avantor, Inc. NYSE:AVTR | 6.55B | -2.0% | -2.4% | 25.2% | |
 Halozyme Therapeutics, Inc. NASDAQ:HALO | 1.40B | 19.0% | 25.8% | 25.3% | |
 HealthEquity, Inc. NASDAQ:HQY | 1.31B | 15.1% | 12.4% | 26.3% | |
 Globus Medical, Inc. NYSE:GMED | 2.94B | 23.3% | 25.1% | 17.9% | |
 Bio-Rad Laboratories, Inc. NYSE:BIO | 2.58B | -1.1% | -2.4% | 2.2% | |
 DaVita Inc. NYSE:DVA | 13.64B | 4.0% | 3.3% | -0.8% | |
 Masimo Corporation NASDAQ:MASI | 1.53B | -9.3% | 4.3% | 7.9% |
Molina Healthcare, Inc. Fair Value Envelope
Related Guides
Continue your MOH research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.